Development of a Canadian Bronchiectasis and NTM Database
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-120
SponsorUniversity of Calgary
About this trial
The investigators aim to develop a comprehensive patient registry of patients with non-CF bronchiectasis and/or Nontuberculosis Mycobacteria (NTM)
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Over the age of 18
Non-CF Bronchiectasis
Nontuberculosis Mycobacteria (NTM)
Disqualifiers
Under the age of 18
CF bronchiectasis
Trial population
Patients over the age of 18 with non-CF Bronchiectasis and/or Nontuberculosis Mycobacteria (NTM).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
2,000 Participants
are grouped into 2 trial groupsGroup A: Non-CF Bronchiectasis Patients with or without NTM
Group B: Nontuberculosis Mycobacteria (NTM)
Trial outcomes
Primary outcomes
1
Patient Recruitment and Data analysis for NTM and Bronchiectasis
Descriptive analysis of demographics and clinical parameters and epidemiological evaluation of No. of hospitalizations, No. of exacerbations.
Time frame
December 2050Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Calgary
Lead sponsor
Insmed Incorporated
Collaborator
Trudell Medical International
Collaborator
Source ClinicalTrials.gov